Market Place
Sourcing Support
All News #Library
Biotech
Cancer Imaging Company Buys Lisata For Ph. 2-Stage Tumor Drug
21 Jan 2026 //
FIERCE BIOTECH
Lisata Therapeutics Wins 2025 BioTech Breakthrough Award
06 Nov 2025 //
GLOBENEWSWIRE
Lisata Therapeutics Showcases Certepetide Preclinical Data
04 Nov 2025 //
GLOBENEWSWIRE
Lisata & Catalent Announce Global ADC License Agreement
08 Oct 2025 //
GLOBENEWSWIRE
Lisata Therapeutics Reveals Positive Data In Pancreatic Cancer
29 Sep 2025 //
GLOBENEWSWIRE
Lisata Therapeutics Reports Q2 2025 Financials, Updates
07 Aug 2025 //
GLOBENEWSWIRE
Lisata Therapeutics, WARPNINE Complete iLSTA Trial Enrollment
17 Jul 2025 //
GLOBENEWSWIRE
Lisata Trial Shows Positive Cohort B Data at ESMO GI
26 Jun 2025 //
GLOBENEWSWIRE
Lisata Therapeutics, GATC Health Expand AI-Driven Drug Discovery
17 Jun 2025 //
GLOBENEWSWIRE
Lisata & Warpnine Show Encouraging Results For Certepetide In PDAC
23 Jan 2025 //
GLOBENEWSWIRE
Lisata Therapeutics Wins BioTech Breakthrough Award 2024
19 Nov 2024 //
GLOBENEWSWIRE
Lisata Signs Research Agreement on Certepetide for Endometriosis
28 Oct 2024 //
#N/A
Lisata`s Certepetide Shows Promise For Intrahepatic Cholangiocarcinoma
10 Jul 2024 //
GLOBENEWSWIRE
Lisata Receives EMA Paediatric Waiver For Certepetide In Pancreatic Cancer
20 May 2024 //
GLOBENEWSWIRE
Lisata & WARPNINE Announce First Patient Treated in the iLSTA Trial of LSTA1
18 Apr 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.